Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.

Waldencast plc

Waldencast is a self-described global beauty and wellness multi-brand platform.

Waldencast

Waldencast is a holding company and investment fund that incubates and accelerates early stage beauty and wellness brands and helps them rapidly create scale and profitability via industry specific operational expertise. Waldencast invests in brand-led business models and goes beyond traditional incubation and acceleration to develop a collective of innovative and unique brands that place responsible entrepreneurship at the heart of its operations.  Waldencast has offices in New York and London and has an investment portfolio in North America, Europe, and Latin America.

The selection of brands to participate in the community is as much driven by the strength of the brand concept and business model as it is by our shared human and social values: sustainability, responsibility, inclusivity.  We believe brands that marry purpose, art, beauty, and design with industry and commerce to make the planet and the lives of those in it better.

Individuals that are part of the Waldencast collective are as much driven by the strength of the brands’ ideas, as it is by sharing our dreamer/maker values: ambition with humility, idealism with practicality, grit with empathy, vision with action.

We have the spirit of a challenger, a disruptor, a game-changer. We are a start-up and we intend to stay in the attitude of a start-up regardless of our success.

Costa Brazil

2024 AWARD WINNING BROW SERUM🎉

InStyle has recognized Obagi Nu-Cil™ Eyebrow Boosting Serum as the Best Brow Serum in their Best Beauty Buys 2024 product roundup! 

“I was introduced to this powerhouse brow serum by board-certified dermatologist Mona Gohara, M.D.  …So it's safe to say I'm hooked.” writes Kara Jillian Brown

Thank you to our Obagi Fam and healthcare providers for the continuous love you show our products.

Visit your Obagi provider to learn more about this great product! 
#obagi #obagimedical #obagiskincare

Read the full article here:
https://lnkd.in/giiJuG-M

We're #hiring a new Amazon Brand Manager in Greater London, England. Apply today or share this post with your network.

Congratulations to our portfolio company C16 Biosciences for this recognition!

We are excited to participate in TD Cowen’s 8th annual conference 2024 with Oliver Chen, CFA and Jonna Kim, CFA.

We’re #hiring a new Glaze North America Key Account Director in United States. Apply today or share this post with your network.

	Dec '20	Dec '21	Dec '21	Dec '22	Dec '23
account payables		12.68M -	272.95K 97.85%	23.87M 8,646.19%	28.09M 17.65%
accumulated other comprehensive income loss		-25K -		-29K -	-151K 420.69%
cash and cash equivalents		12.79M -	1.50M 88.25%	8.69M 478.08%	22.58M 159.70%
cash and short term investments		12.79M -	1.50M 88.25%	8.69M 478.08%	22.58M 159.70%
common stock		4M -	345.00M 8,525.02%	10K 100.00%	11K 10%
deferred revenue				10.29M -
deferred revenue non current					15.53M -
deferrred tax liabilities non current		548K -		22.25M -	15.23M 31.56%
goodwill		44.49M -		334.62M -	334.62M 0%
goodwill and intangible assets		124.06M -		973.78M -	917.48M 5.78%
intangible assets		79.57M -		639.16M -	582.86M 8.81%
inventory		21.61M -		54.38M -	55.68M 2.39%
long term debt		103.42M -	1.50M 98.55%	177.11M 11,707.40%	151.26M 14.59%
long term investments
net debt		106.07M -	-3.77K 100.00%	190.55M 5,057,265.61%	155.15M 18.58%
net receivables		18.74M -		19.54M -	22.43M 14.77%
other assets			1.36B -
other current assets		279K -	204.82K 26.59%	679K 231.51%	6.64M 877.32%
other current liabilities		12.68M -	95K 99.25%	26.50M 27,790.53%	23.70M 10.56%
other liabilities
other non current assets		288K -	345.09M 119,721.21%	535K 99.84%	380K 28.97%
other non current liabilities		571K -	54.73M 9,485.77%	18.31M 66.55%	28.70M 56.73%
othertotal stockholders equity		100.11M -		796.04M -	871.53M 9.48%
preferred stock
property plant equipment net		1.20M -		24.71M -	17.52M 29.10%
retained earnings	-10.95K -	-64.85M 592,074.23%	-54.81M 15.48%	-156.78M 186.04%	-246.76M 57.39%
short term debt		15.44M -		22.14M -	10.93M 50.63%
short term investments
tax assets
tax payables
total assets	166.79K -	184.59M 110,568.38%	1.71B 825.64%	1.09B 36.20%	1.04B 4.35%
total current assets		59.04M -	1.71M 97.11%	91.04M 5,228.55%	107.33M 17.89%
total current liabilities	177.74K -	40.80M 22,857.30%	367.95K 99.10%	72.50M 19,604.96%	62.71M 13.50%
total debt		118.86M -	1.50M 98.74%	199.25M 13,183.13%	177.72M 10.80%
total investments
total liabilities	177.74K -	145.35M 81,673.68%	56.60M 61.06%	290.18M 412.66%	273.44M 5.77%
total liabilities and stockholders equity	166.79K -	184.59M 110,568.38%	346.79M 87.88%	1.09B 214.33%	1.04B 4.35%
total non current assets	166.79K -	125.55M 75,172.79%	345.09M 174.86%	999.03M 189.50%	935.38M 6.37%
total non current liabilities		104.54M -	56.23M 46.21%	217.67M 287.08%	210.72M 3.19%
total stockholders equity	-10.95K -	39.24M 358,414.31%	290.19M 639.55%	639.24M 120.28%	624.63M 2.29%

NASDAQ:WALD

Waldencast

Last Close

3.47

26/07 20:00

Market Cap

456.93M

Beta: -

Volume Today

73.17K

Avg: 5.58K

PE Ratio

−2.75

PFCF: 366.52

Preview